Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with antibody-drug conjugates

Combination therapy with antibody-drug conjugates

US Patent 8263083 · Granted Sep 11, 2012

Estimated economic value: $28,977,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-EDB antibodies and antibody-drug conjugates2023
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates2023
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates2022
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates2021
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates2021
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates2021
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates2020
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates2019
Methods for detecting 5T4-positive circulating tumor cells and methods of diagno2019
Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates2018
Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates2017
Anti-VEGF antibodies2016